Total Payments
$130,232
2024 Payments
$2,230
Companies
28
Transactions
213
Medicare Patients
47,193
Medicare Billing
$2.1M
Payment Breakdown by Category
Other$119,983 (92.1%)
Travel$5,442 (4.2%)
Food & Beverage$4,795 (3.7%)
Education$11.56 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119,713 | 58 | 91.9% |
| Travel and Lodging | $5,442 | 24 | 4.2% |
| Food and Beverage | $4,795 | 129 | 3.7% |
| Debt forgiveness | $270.00 | 1 | 0.2% |
| Education | $11.56 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $128,736 | 151 | $0 (2024) |
| Baxter Healthcare | $270.00 | 1 | $0 (2024) |
| Medtronic USA, Inc. | $187.31 | 5 | $0 (2017) |
| Lilly USA, LLC | $143.94 | 9 | $0 (2022) |
| Galderma Laboratories, L.P. | $91.07 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $86.42 | 5 | $0 (2021) |
| Kowa Pharmaceuticals America, Inc. | $85.89 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $70.07 | 4 | $0 (2018) |
| Teva Pharmaceuticals USA, Inc. | $67.78 | 4 | $0 (2019) |
| Allergan, Inc. | $64.24 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,230 | 3 | Novo Nordisk Inc ($1,960) |
| 2023 | $5,633 | 8 | Novo Nordisk Inc ($5,619) |
| 2022 | $11,004 | 14 | Novo Nordisk Inc ($10,873) |
| 2021 | $14,867 | 22 | Novo Nordisk Inc ($14,767) |
| 2020 | $7,313 | 23 | Novo Nordisk Inc ($7,068) |
| 2019 | $30,979 | 39 | Novo Nordisk Inc ($30,810) |
| 2018 | $33,264 | 55 | Novo Nordisk Inc ($33,066) |
| 2017 | $24,941 | 49 | Novo Nordisk Inc ($24,574) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/04/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,235.00 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | Baxter Healthcare | — | Debt forgiveness | In-kind items and services | $270.00 | General |
| 08/31/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 08/24/2023 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 08/10/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,160.00 | General |
| Category: Diabetes | ||||||
| 06/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2023 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 05/18/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $725.00 | General |
| Category: Diabetes | ||||||
| 04/25/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,543.75 | General |
| 11/14/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.21 | General |
| 10/31/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $631.13 | General |
| Category: Diabetes | ||||||
| 10/11/2022 | Kowa Pharmaceuticals America, Inc. | Seglentis (Drug) | Food and Beverage | Cash or cash equivalent | $85.89 | General |
| Category: Pain Management | ||||||
| 08/31/2022 | Tactile Systems Technology Inc | Flexitouch Plus (Device), entre | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 08/19/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,755.00 | General |
| Category: Diabetes | ||||||
| 08/19/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
| 08/02/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,362.50 | General |
| Category: Diabetes | ||||||
| 08/02/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Diabetes | ||||||
| 06/16/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,767.50 | General |
| Category: Diabetes | ||||||
| 06/16/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $94.76 | General |
| Category: Diabetes | ||||||
| 04/09/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,377.00 | General |
| Category: Diabetes | ||||||
| 02/25/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 02/24/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,755.00 | General |
| Category: Diabetes | ||||||
| 02/24/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $89.32 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 45 | 12,358 | 17,005 | $913,645 | $238,337 |
| 2022 | 73 | 11,561 | 19,049 | $1.3M | $483,818 |
| 2021 | 91 | 11,075 | 21,023 | $1.7M | $723,718 |
| 2020 | 90 | 12,199 | 23,313 | $1.9M | $689,742 |
Total Patients
47,193
Total Services
80,390
Medicare Billing
$2.1M
Procedure Codes
299
All Medicare Procedures & Services
299 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 225 | 400 | $76,305 | $30,293 | 39.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 1,200 | 1,664 | $140,328 | $27,350 | 19.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 602 | 750 | $69,150 | $21,720 | 31.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 1,040 | 1,449 | $65,113 | $18,964 | 29.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 1,193 | 1,675 | $68,735 | $17,318 | 25.2% |
| 83721 | Ldl cholesterol level | Office | 2023 | 941 | 1,274 | $78,800 | $13,082 | 16.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,102 | 1,368 | $13,680 | $11,491 | 84.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 949 | 1,476 | $38,855 | $11,220 | 28.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 120 | 231 | $17,155 | $9,924 | 57.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 711 | 942 | $46,424 | $8,317 | 17.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 531 | 713 | $30,930 | $6,770 | 21.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 505 | 792 | $37,062 | $6,565 | 17.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 47 | $10,128 | $5,839 | 57.7% |
| 80076 | Liver function blood test panel | Office | 2023 | 402 | 565 | $24,526 | $4,526 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 77 | $12,012 | $4,461 | 37.1% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 568 | 719 | $35,431 | $4,057 | 11.5% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 26 | 48 | $7,372 | $3,754 | 50.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $5,028 | $3,584 | 71.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 538 | 684 | $19,605 | $3,461 | 17.7% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 110 | 135 | $23,040 | $3,414 | 14.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 16 | 16 | $6,552 | $3,376 | 51.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 193 | 207 | $22,512 | $3,059 | 13.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 504 | 759 | $14,182 | $2,349 | 16.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 62 | $4,030 | $2,164 | 53.7% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 84 | 94 | $8,573 | $1,694 | 19.8% |
About Dr. Monzer Yazji, MD
Dr. Monzer Yazji, MD is a Internal Medicine healthcare provider based in Edinburg, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619998838.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Monzer Yazji, MD has received a total of $130,232 in payments from pharmaceutical and medical device companies, with $2,230 received in 2024. These payments were reported across 213 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($119,713).
As a Medicare-enrolled provider, Yazji has provided services to 47,193 Medicare beneficiaries, totaling 80,390 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 299 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Edinburg, TX
- Active Since 07/22/2006
- Last Updated 06/20/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619998838
Products in Payments
- Tresiba (Drug) $38,751
- Ozempic (Drug) $31,697
- RYBELSUS (Drug) $14,741
- Rybelsus (Drug) $14,208
- Xultophy 100/3.6 (Drug) $7,095
- Victoza (Drug) $2,834
- NUVENT (Device) $187.31
- Seglentis (Drug) $85.89
- TRULICITY (Drug) $79.69
- VRAYLAR (Drug) $64.24
- Omnipod (Device) $64.07
- SOLIQUA (Drug) $55.75
- Saxenda (Drug) $49.79
- FreeStyle Libre (Device) $45.34
- FARXIGA (Drug) $43.48
- TROKENDI XR (Drug) $38.56
- AUSTEDO (Drug) $37.91
- EMGALITY (Drug) $34.48
- AFREZZA (Drug) $34.21
- BREZTRI (Drug) $31.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Edinburg
Dr. Eduardo Luna, M.d, M.D
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Augustine George, Md, MD
Internal Medicine — Payments: $17,406
Internal Medicine $17,406
Moses Tarhsong Ashukem, Md, MD
Internal Medicine — Payments: $12,524
Internal Medicine $12,524
Dr. Antonio Wong, Md, MD
Internal Medicine — Payments: $6,497
Internal Medicine $6,497
Dr. Leonel Villarreal Cantu, M.d, M.D
Internal Medicine — Payments: $5,697
Internal Medicine $5,697
Socrates Garrigos, Md, MD
Internal Medicine — Payments: $3,933
Internal Medicine $3,933